Ambu has been awarded a contract with the US-based healthcare services provider Vizient, the Danish medtech company reports in a press release.
According to the firm, the deal will accelerate Ambu's fast-growing share of the single-use endoscope market. Vizient will aid this market expansion by offering its members Ambu's portfolio of products within bronchoscopy, urology, ENT and gastrointestinal endoscopy with pre-negotiated pricing and terms.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.